Cargando…

Changing Impact of Modifiable Risk Factors on the Incidence of Major Outcomes of Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study

OBJECTIVE: The incidence of type 1 diabetes complications appears to be decreasing, but relative contributions of risk factors are unclear. We thus estimated the effect of modifiable risk factors on the incidence of a composite end point, major outcomes of diabetes (MOD). RESEARCH DESIGN AND METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Rachel G., Secrest, Aaron M., Ellis, Demetrius, Becker, Dorothy J., Orchard, Trevor J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836155/
https://www.ncbi.nlm.nih.gov/pubmed/24170748
http://dx.doi.org/10.2337/dc13-1142
_version_ 1782292278700670976
author Miller, Rachel G.
Secrest, Aaron M.
Ellis, Demetrius
Becker, Dorothy J.
Orchard, Trevor J.
author_facet Miller, Rachel G.
Secrest, Aaron M.
Ellis, Demetrius
Becker, Dorothy J.
Orchard, Trevor J.
author_sort Miller, Rachel G.
collection PubMed
description OBJECTIVE: The incidence of type 1 diabetes complications appears to be decreasing, but relative contributions of risk factors are unclear. We thus estimated the effect of modifiable risk factors on the incidence of a composite end point, major outcomes of diabetes (MOD). RESEARCH DESIGN AND METHODS: The Pittsburgh Epidemiology of Diabetes Complications (EDC) Study was used to derive two cohorts based on diabetes diagnosis year (1960–1969 and 1970–1980). Baseline exam data in the current analysis for the 1960s group were collected in 1986–1988 and for the 1970s in 1996–1998. Each group was followed for 8 years for MOD incidence (diabetes-related death, myocardial infarction, revascularization procedure/blockage ≥50%, stroke, end-stage renal disease, blindness, and amputation). Assessed risk factors include the following: HbA(1c), hypertension, microalbuminuria, BMI, hypercholesterolemia, and smoking. Accelerated failure time models were used to estimate the acceleration factor. RESULTS: MOD incidence decreased in the 1970s cohort (15.8% [95% CI 11.6–21.4]) compared with the 1960s (22.6% [17.0–29.1]) over the 8-year follow-up (P = 0.06). Hypertension and microalbuminuria were associated with significantly accelerated MOD incidence in both cohorts (P < 0.01 for both). High HbA(1c) (P = 0.0005), hypercholesterolemia (P = 0.01), and current smoking (P = 0.003) significantly accelerated the incidence of MOD in the 1960s but not 1970s cohort. BMI was not associated with MOD in either cohort. CONCLUSIONS: These results suggest that hypertension and microalbuminuria remain important predictors of complications that are not being adequately addressed.
format Online
Article
Text
id pubmed-3836155
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-38361552014-12-01 Changing Impact of Modifiable Risk Factors on the Incidence of Major Outcomes of Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study Miller, Rachel G. Secrest, Aaron M. Ellis, Demetrius Becker, Dorothy J. Orchard, Trevor J. Diabetes Care Original Research OBJECTIVE: The incidence of type 1 diabetes complications appears to be decreasing, but relative contributions of risk factors are unclear. We thus estimated the effect of modifiable risk factors on the incidence of a composite end point, major outcomes of diabetes (MOD). RESEARCH DESIGN AND METHODS: The Pittsburgh Epidemiology of Diabetes Complications (EDC) Study was used to derive two cohorts based on diabetes diagnosis year (1960–1969 and 1970–1980). Baseline exam data in the current analysis for the 1960s group were collected in 1986–1988 and for the 1970s in 1996–1998. Each group was followed for 8 years for MOD incidence (diabetes-related death, myocardial infarction, revascularization procedure/blockage ≥50%, stroke, end-stage renal disease, blindness, and amputation). Assessed risk factors include the following: HbA(1c), hypertension, microalbuminuria, BMI, hypercholesterolemia, and smoking. Accelerated failure time models were used to estimate the acceleration factor. RESULTS: MOD incidence decreased in the 1970s cohort (15.8% [95% CI 11.6–21.4]) compared with the 1960s (22.6% [17.0–29.1]) over the 8-year follow-up (P = 0.06). Hypertension and microalbuminuria were associated with significantly accelerated MOD incidence in both cohorts (P < 0.01 for both). High HbA(1c) (P = 0.0005), hypercholesterolemia (P = 0.01), and current smoking (P = 0.003) significantly accelerated the incidence of MOD in the 1960s but not 1970s cohort. BMI was not associated with MOD in either cohort. CONCLUSIONS: These results suggest that hypertension and microalbuminuria remain important predictors of complications that are not being adequately addressed. American Diabetes Association 2013-12 2013-11-13 /pmc/articles/PMC3836155/ /pubmed/24170748 http://dx.doi.org/10.2337/dc13-1142 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Original Research
Miller, Rachel G.
Secrest, Aaron M.
Ellis, Demetrius
Becker, Dorothy J.
Orchard, Trevor J.
Changing Impact of Modifiable Risk Factors on the Incidence of Major Outcomes of Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study
title Changing Impact of Modifiable Risk Factors on the Incidence of Major Outcomes of Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study
title_full Changing Impact of Modifiable Risk Factors on the Incidence of Major Outcomes of Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study
title_fullStr Changing Impact of Modifiable Risk Factors on the Incidence of Major Outcomes of Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study
title_full_unstemmed Changing Impact of Modifiable Risk Factors on the Incidence of Major Outcomes of Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study
title_short Changing Impact of Modifiable Risk Factors on the Incidence of Major Outcomes of Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study
title_sort changing impact of modifiable risk factors on the incidence of major outcomes of type 1 diabetes: the pittsburgh epidemiology of diabetes complications study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836155/
https://www.ncbi.nlm.nih.gov/pubmed/24170748
http://dx.doi.org/10.2337/dc13-1142
work_keys_str_mv AT millerrachelg changingimpactofmodifiableriskfactorsontheincidenceofmajoroutcomesoftype1diabetesthepittsburghepidemiologyofdiabetescomplicationsstudy
AT secrestaaronm changingimpactofmodifiableriskfactorsontheincidenceofmajoroutcomesoftype1diabetesthepittsburghepidemiologyofdiabetescomplicationsstudy
AT ellisdemetrius changingimpactofmodifiableriskfactorsontheincidenceofmajoroutcomesoftype1diabetesthepittsburghepidemiologyofdiabetescomplicationsstudy
AT beckerdorothyj changingimpactofmodifiableriskfactorsontheincidenceofmajoroutcomesoftype1diabetesthepittsburghepidemiologyofdiabetescomplicationsstudy
AT orchardtrevorj changingimpactofmodifiableriskfactorsontheincidenceofmajoroutcomesoftype1diabetesthepittsburghepidemiologyofdiabetescomplicationsstudy